Re: T-DM1 Compassonate Use
Reading the articles under which the FDA operates I would think that plenty of data have been captured (not all made public) from the T-DM1 phase II trials in 3rd line setting to justify compassionate use of this drug.
Don't believe companies and oncologists are overly eager to take on the additional paperwork to document unapproved drug's performance that is required by such program.
|